Table 1.
Physical characteristics Cardiometabolic risk factors of study participants.
| Variable | Non-Obese Controls | Obese Bariatric Patients | p-Value |
|---|---|---|---|
| n | 40 (18 ♂) | 40 (12 ♂) | |
| Age, y | 35.4 ± 1.3 | 36.2 ± 1 | 0.339 |
| Weight, kg | 74.4 ± 1.6 | 142.4 ± 3.7 * | <0.001 |
| BMI, kg/ m2 | 24.9 ± 0.5 | 50.6 ± 1.1 * | <0.001 |
| WC, cm | 131.5 ± 4 | 91.5 ± 2 * | <0.001 |
| Body fat, % | 32.2 ± 2.5 | 52.3 ± 1.0 * | <0.001 |
| Body lean, % | 65.3 ± 2.4 | 46.5 ± 0.9 * | <0.001 |
| VAT mass, kg | 0.7 ± 0.1 | 2.0 ± 0.2 * | 0.0002 |
| HR, bpm | 74 ± 2 | 81 ± 1 * | 0.004 |
| SBP, mmHg | 118 ± 2 | 132 ± 2 * | <0.001 |
| DBP, mmHg | 75 ± 1 | 80 ± 1 * | 0.013 |
| FPG, mg/dL | 92 ± 2 | 103 ± 5 | 0.112 |
| FPI, µU/mL | 8.4 ± 1.4 | 14.9 ± 2.8 * | <0.001 |
| HOMA-IR | 1.9 ± 0.1 | 4.1 ± 0.4 * | 0.002 |
| HbA1c, % | 5.3 ± 0.1 | 5.8 ± 0.2 | 0.148 |
| Total chol, mg/dL | 155 ± 9 | 165 ± 4 | 0.171 |
| HDL, mg/dL | 56 ± 6 | 43 ± 1 * | <0.001 |
| LDL, mg/dL | 87 ± 7 | 99 ± 4 | 0.116 |
| TG, mg/dL | 92 ± 11 | 115 ± 8 | 0.136 |
| IL6, pg/mL | 5.2 ± 0.7 | 21.6 ± 3.6 * | 0.001 |
| IL8, pg/mL | 3.0 ± 0.1 | 4.9 ± 0.4 * | <0.001 |
| CRP, mg/L | 0.7 ± 0.1 | 3.8 ± 0.2 * | <0.0001 |
BMI, body mass index; Chol, cholesterol; cm, centimeters; CRP, C-reactive protein; DBP, diastolic blood pressure; FPG, fasting plasma glucose; FPI, fasting plasma insulin; HDL, high density lipoprotein; HOMA-IR, Homeostatic model assessment for insulin resistance; HR, heart rate; IL6, interleukin 6; IL8, interleukin 8; kg, kilograms; LDL, low density lipoprotein; n, number; SBP. Systolic blood pressure; TG, triglycerides; VAT, visceral adipose tissue; WC, waist circumference; y, years; ♂, males; * p < 0.05.